CITIC: Maintain a "buy" rating for tongchengtravel with a fair value of 20.18 HKD.
CICC released a research report predicting that tongchengtravel (00780) will generate revenue of 17.2/20.1/24 billion yuan in 2024-2026, representing year-on-year growth of 44.2%/17.2%/19.5%. The non-IFRS net income is expected to be 2.72/3.34/4.02 billion yuan, with year-on-year growth of 24.4%/22.6%/20.5%. The reasonable value is HKD 20.18 per share, maintaining a "buy" rating. Tongchengtravel announced its Q3 2024 financial report. According to the company's financial report, the GMV for Q3 2024 grew by 2.4% year-on-year to 72.8 billion yuan, revenue
Express News | Two innovative drugs from johnson & johnson have been included in the new national medical insurance catalog.
UnitedHealth, 3M Share Gains Contribute To Dow's 119-Point Jump
Dow's 115-Point Rally Highlighted By Gains For Amazon.Com Inc., Walmart Shares
Deutsche Bank Adjusts Price Target on 3M to $158 From $161, Keeps Buy Rating
Wells Fargo Maintains 3M(MMM.US) With Hold Rating, Maintains Target Price $140